These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Comparative study on the clinical effects and endometrial findings of IUD]. Author: Chao CK. Journal: Toho Igakkai Zasshi; 1988 Mar; 34(6):550-60. PubMed ID: 12343145. Abstract: Clinical effects of IUD and its related endometrial changes in 418 women were studied. Typical subjects had their IUDs inserted in their mid to late 20s after 3 pregnancies and 2 child births. Major endometrial changes included leukocyte, endometrial hyperplasia, squamous metaplasia, but no malignant changes were noted. Of 418, 327 had CU-medicated IUDs (Group I) and 91 had non-medicated IUDs (Group II). Group I consisted of 259 users of Copper T-200, 35 users of multi load CU-250, 33 users of Nova T-200. Group II consisted of 54 users of Spira-ring and 37 users of Lippes loop. There was no significant difference between the 2 groups in duration of IUD use. 1/3 of all subjects had their IUDs removed within a year. 80% of CU-medicated IUDs were removed in 1 to 3 years. 20% of both groups removed IUDs because of excessive discharge; 60%, because of genital bleeding; 25%, because of pregnancy. 20% of both groups also complained of pain. The rate of removal due to side-effects was significantly lower in Group I than Group II (p0.001), although the removal due to side-effects took place earlier in Group I than Group II (P0.005). CU-medicated IUDs had lower rate of removal due to pregnancy than non-medicated group (p0.001). 8 cases of all subjects had inflammatory reaction within 2 years of insertion; 27 cases (6.5%), endometrial proliferative activity within 3 years. 7 cases of 259 Copper-T users had squamous metaplasia within two years of insertion. In conclusion, periodic pap smear test should be conducted on IUD users.[Abstract] [Full Text] [Related] [New Search]